Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015.

Slides:



Advertisements
Similar presentations
UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.
Advertisements

OPTN Regional Meetings Data Update Spring OPTN 2007 Donor, Transplant, and Waiting List Numbers.
Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University
David Taber, Charles Bratton, Angello Lin, John McGillicuddy, Kenneth Chavin and Prabhakar Baliga.
The New Kidney Allocation System: What Referring Physicians Need to Know The OPTN presents: The New Kidney Allocation System: What Referring Physicians.
SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.
Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.
Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
Basics of Organ Transplantation Lon Eskind, MD Director Liver Transplant, CMC Assoc. Medical Director of LifeShare.
DIALYSIS OR TRANSPLANTATION Ahmed Halawa MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition TRANSPLANT WAITING LIST CHAPTER 7.
Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant.
AN ANALYSIS OF CADAVER DONOR AND KIDNEY BIOPSY PARAMETERS WITH CORRELATION TO TRANSPLANT OUTCOMES Martin Mozes MD, Mel Schwartz MD, Janis Orlowski MD Michael.
Desensibilização em transplante renal – experiência da PUCRS (relato de caso) HOSPITAL SÃO LUCAS DA PUCRS SERVIÇO DE NEFROLOGIA 2012 David Saitovitch.
Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.
What makes a pancreas allograft marginal? Peter J Friend University of Oxford.
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
The Deceased Donor Kidney Allocation System
Facing the Organ Shortage Crisis: Business as Usual vs Non- Conventional Solutions? Richard Perez MD Division of Transplant Surgery UC Davis Medical Center.
Proposal to Substantially Revise the National Kidney Allocation System
“Yes Minister, we can deliver cheaper kidney care” Lisa Burnapp Lead Nurse-Living Donation, NHS Blood & Transplant Consultant Nurse-Living Donor Kidney.
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
Patient Survival USA Primary DD Pancreas Transplants 1/1/2004 – 12/31/2008 Categoryn 1Yr Surv. PTA % PAK1, % SPK4, % 2/09.
A Mission to Save More Lives Where we’ve been, where we are, and where we need to be Thomas A. Nakagawa, M.D, FAAP, FCCM Professor, Anesthesiology and.
Allocation of elderly deceased donor kidneys Lisa Bradbury, Niaz Ahmad, Paul Gibbs, Richard Baker, Adam McLean, Chris Callaghan Renal Transplant Services.
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
David C. Mulligan, MD, FACS
BWGHF Liège Heart transplantation 2008.
CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,
PAIRED EXCHANGE KIDNEY TRANSPLANTATION EXPERIENCE OF TURKEY Levent Yucetin MD. Antalya Medicalpark Healthcare Group Transplant Center Senior Transplant.
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
The New Kidney Allocation System Gautham Mogilishetty, MD Associate Professor of Medicine Division of Nephrology and Transplantation University of Cincinnati.
Section 3: CKD, CVD and mortality. Cardiovascular diseases in CKD patients Damage to the heart (Uraemic cardiomyopathy ) Damage to the arteries (Uraemic.
Experiência Brasileira em Dessensibilizacão Pré-Transplante Renal. Maria Cristina Ribeiro de Castro Serviço de Transplante Renal e Laboratório de Imunologia.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
The Expanded Criteria Donors in Kidney Transplantation: 3 Years Experience FAM Shaheen, B. Al-Attar, MZ Souqiyyeh, J.E Cillo, A. Al Sayyari.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
© 2014 Direct One Communications, Inc. All rights reserved. 1 How to Maximize Outcomes and Minimize Graft Failure Thin Thin Maw, MBBS Washington University.
1 OPTN Update Brian Shepard Chief Executive Officer UNOS November 17, 2015.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
David A. Gerber, MD Professor and Chief Division of Abdominal Transplantation Department of Surgery University of North Carolina at Chapel Hill.
Graham Lipkin September 23 rd 2014 West Midlands Renal Network Transplant Education & Audit.
Minority Affairs Committee Fall  Patient resource promoting early referral for transplant evaluation  Collaborated with Patient Affairs Committee.
1 Kidney Transplantation Committee Spring Recent Public Comment Proposals  OPTN Kidney Paired Donation (KPD) Priority Points  Changes apply.
UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
Impact of Recipient and Donor Non-immunological factors on the Outcome of Expanded Criteria Deceased Donors Kidney Transplantation Dr Hajar Al Hayyan.
Scottish Renal Registry Report 2009 Section D - Kidney Transplantation Published by the Information Services Division (ISD Scotland), Common Services Agency.
New kidney offering scheme … Lorna Marson Deputy Chair, Kidney Advisory Group Work in progress.
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
The significance of Focal C4d+: The WU experience Helen Liapis, M.D. Professor of Pathology & immunology Kedainis RL et al. Am J Transplant Apr;9(4):812-9.
USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged
BUONA FUNZIONE RENALE DEI TRAPIANTI RENALI DA DONATORI ANZIANI VALUTATI CON CLEARANCE DELLA CREATININA SECONDO GAULT-COCKCROFT, CON DATI ECOGRAFICI E CON.
Living Donor Transplants
Number of transplants, by donor type figure 8.1
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Liver Transplantation: 50 years
OPTN/UNOS Kidney Transplantation Committee
Risk factors in deceased-donor transplants Risk factor 1988
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Risk Factors associated with Outcome
Kidney and Kidney/Pancreas Transplantation in a Year
Patient characteristics: American vs Canadian transplant patients
MPSC Transplant Program Performance Measures (Outcome Measures)
Representative Light Micrographs of Kidney Sections Illustrating the Histologic Scoring Criteria Giuseppe Remuzzi, et al, N Engl J Med 2006;3354:
UK Renal Registry 9th Annual Report 2006
Cumulative survival curves for deceased-donor transplant recipients who were older than 70 yr and similarly aged dialysis patients who were on the waiting.
Presentation transcript:

Making the Most at the Margins Improving Organ Utilization and Recipient Outcomes. Jared C Brandenberger MD UNOS Region 6 Educational Forum March 6, 2015

© 2014 Virginia Mason Objectives Review current trends in recipient and donor populations. Review donor and transplant trends at Virginia Mason over the past 5 years Review the use of unconventional donors in our program 2

© 2014 Virginia Mason Need As of 07:12AM 03/05/15: –101,585 patients on the kidney waitlist 16,894 total transplants in 2013 –11,161 Deceased donor –5,733 living donor –13,124 Jan-Nov % Dialysis patients die annually Wolfe et al. NEJM, 1999 OPTN data

© 2014 Virginia Mason Need 2011 OPTN Annual Report

© 2014 Virginia Mason Need 2011 OPTN Annual Report

© 2014 Virginia Mason Recipient Age OPTN Data

© 2014 Virginia Mason Expanded Recipient Population Older recipients Recipients with higher immunologic risk Desensitization HIV positive recipients

© 2014 Virginia Mason Need Renal Transplantation is safe –Survival advantage –Quality of life Recipient age and complexity are increasing Organ supply is not Port et al. JAMA, 1993 Russel et al. Transplantation, 1992

© 2014 Virginia Mason 9

Use of Unconventional Donors 10

© 2014 Virginia Mason Use of Unconventional Donors 11

© 2014 Virginia Mason Outcomes 12

© 2014 Virginia Mason ECD/KDPI >85% Donor –67 yo female fall from ladder –KDPI 94% –CDC increased risk - hemodilution –Height 5'5'' Weight 50kg, BMI 18 –Terminal creat 1.4 (Admit 0.9) –Biopsy shows 5-15% sclerosis 13 Recipient –70-year-old female –CPRA 0% –53 kg –CKD V 2/2 DM

© 2014 Virginia Mason ECD/KDPI >85% 2 for 1-Dual grafts 3mg/kg thymo induction Low intensity belatacept protocol (mmf, pred 5) Early BK Nephropathy-Resolved Creat Nadir 1.2 and stable at 1yr 14

© 2014 Virginia Mason ECD/KDPI >85% 15 Hefty et al. Urology, 1998

© 2014 Virginia Mason ECD/KDPI >85% 1.5 to 3 year wait time 98% overall graft survival last 5y 87.0%; 61.7%; 30.5% - 1, 3, and 5 yr survival nationwide Creation of local expedited placement list 16 SRTR Data